Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing
- 413 Downloads
Cutaneous carcinosarcoma (CCS) is an extraordinarily rare neoplasm with a biphasic morphological pattern exhibiting both epithelial and sarcomatoid components. Although its histogenesis and biological aspects remain poorly understood, previous studies have postulated that this tumor may arise from single cancer stem cells which subsequently differentiate into distinct tumor lineages. In this study, we explored a wide array of mutational hot spot regions, through high-depth next-generation sequencing of 47 cancer-associated genes in order to assess the mutational landscape of these tumors and investigate whether the epithelial and mesenchymal components shared the same genetic signatures. Results from this study confirm that despite their striking phenotypic differences, both elements of this infrequent tumor indeed share a common clonal origin. Additionally, CCS appears to embrace a heterogeneous spectrum with specific underlying molecular signatures correlating with the defining epithelial morphotype, with those carcinosarcomas exhibiting a squamous cell carcinoma epithelial component exhibiting diverse point mutations and deletions in the TP53 gene, and those with a basal cell carcinoma morphotype revealing a more complex mutational landscape involving several genes. Also, the fact that our findings involve several targetable gene pathways suggests that the underlying molecular events driving the pathogenesis of CCS may represent future potential targets for personalized therapies.
KeywordsCarcinosarcoma Cutaneous Mutations Next-generation sequencing Stem cells Histogenesis
Conflict of interest
The authors declare no conflict of interest.
- 16.Armstrong AB, Wang M, Eble JN, MacLennan GT, Montironi R, Tan PH, Lopez-Beltran A, Zhang S, Baldridge LA, Spartz H, Cheng L (2009) TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol 22:113–118PubMedCrossRefGoogle Scholar
- 17.Sung MT, Wang M, MacLennan GT, Eble JN, Tan PH, Lopez-Beltran A, Montironi R, Harris JJ, Kuhar M, Cheng L (2007) Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol 211:420–430PubMedCrossRefGoogle Scholar
- 19.Routbort M, Patel KP, Singh RR et al (2012) OncoSeek-A versatile annotation and reporting system for next generation sequencing-based clinical mutation analysis of cancer specimens. J Mol Diagn 14:747Google Scholar
- 21.Donnell CA, Pollock WJ, Sybers WA (1987) Thyroid carcinosarcoma. Arch Pathol Lab Med 12:1169–1172Google Scholar
- 23.Arend R, Doneza JA, Wright JD (2011) Uterine carcinosarcoma. Curr Opin Oncol 5:531–536Google Scholar
- 43.Yang CM, Hsieh HL, Yao CC et al (2009) Protein kinase C-delta transactivates platelet-derived growth factor receptor-alpha in mechanical strain-induced collagenase 3 (matrix metalloproteinase-13) expression by osteoblast-like cells. J Biol Chem 284:26040–26050PubMedCentralPubMedCrossRefGoogle Scholar